Stay updated on Montelukast Efficacy in Antibody Infusion Reactions Clinical Trial
Sign up to get notified when there's something new on the Montelukast Efficacy in Antibody Infusion Reactions Clinical Trial page.

Latest updates to the Montelukast Efficacy in Antibody Infusion Reactions Clinical Trial page
- Check4 days agoChange DetectedA new revision entry 'Revision: v3.3.3' was added to the study record history. The references to 'HHS Vulnerability Disclosure' and the prior 'Revision: v3.3.2' note were removed.SummaryDifference0.2%

- Check12 days agoChange DetectedNew entries on 2025-12-15 indicate Results Posted and include updates to Outcome Measures (Results) and Study Status. The prior version on 2025-11-26 also shows Study Status updates.SummaryDifference0.6%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedVersion 10 (2025-11-24) adds Adverse Events, Outcome Measures (Results), Baseline Characteristics, Participant Flow, and other Document Sections; it shows Quality Control Review Not Concluded and Revision: v3.3.2, while Revision: v3.3.1 was removed.SummaryDifference1%

- Check33 days agoChange DetectedThe page history shows a minor revision update from v3.2.0 to v3.3.1; no changes to study details or results are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedThe notice about government funding and operating status was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check55 days agoChange DetectedThe new screenshot shows the same Record History content with no new entries or status changes; any differences appear to be cosmetic layout/UI adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Montelukast Efficacy in Antibody Infusion Reactions Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Montelukast Efficacy in Antibody Infusion Reactions Clinical Trial page.